CSL Ltd (OTCPK:CMXHF)
$ 180.04 -7.51 (-4%) Market Cap: 87.63 Bil Enterprise Value: 101.81 Bil PE Ratio: 33.03 PB Ratio: 5.14 GF Score: 96/100

CSL Ltd R&D Investor Briefing Transcript

Dec 03, 2019 / 10:00PM GMT
Release Date Price: $184.21 (-3.62%)
Mark Dehring
CSL Limited - Head of IR

Good morning, ladies and gents. We'll make a start. Welcome to CSL's Annual Research and Development Briefing. Our first speaker and host today is Dr. Bill Mezzanotte, Executive Vice President and Head of Research and Development.

Before we start, be aware this presentation is being webcast, and please use the microphones during the question-and-answer session. Please note the forward disclaimer statement contained in your packs.

And with that short introduction, I'll pass you over to Bill. Bill?

William Mezzanotte
CSL Limited - Executive VP and Head of Research & Development of CSL Behring

Good morning. Thanks, Mark, and welcome. I'm Bill Mezzanotte. I took over as Head of R&D last year, and I'm running the R&D Day today. Before we start, I'd just like to acknowledge Andrew Cuthbertson, who's in the audience -- Andrew, for his leadership and support over the past few years while I've been here and also, of course, many years in running this day. And Andrew will be around all morning, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot